Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05504070 · ClinicalTrials.gov registry record · NA
Venclose digiRF System Post Market Study
A NA study of Chronic Venous Insufficiency and Venous Reflux, sponsored by C. R. Bard.
- Active
- Registry status
- NA
- Development phase
- 203
- Enrollment target
- 7
- Study locations
NCT05504070: Active NA study of Chronic Venous Insufficiency and Venous Reflux, sponsored by C. R. Bard.
NCT05504070 is a NA study of Chronic Venous Insufficiency and Venous Reflux that is active but no longer recruiting, run by C. R. Bard. The registered enrollment target is 203 participants, above the 109-participant average among 3 other Chronic Venous Insufficiency trials with a reported enrollment target (86% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05504070, a NA study of Chronic Venous Insufficiency and Venous Reflux, is active but no longer recruiting, sponsored by C. R. Bard.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
- 7
- Study locations
Study Summary
A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins.
Primary Outcome
Cumulative Incidence of Occlusion
Conditions Studied
Interventions
- DEVICE Venclose System (digiRF generator w EVSRF catheter)
- DEVICE Venclose MAVEN System (digiRF generator w MAVEN catheter)
Study Locations (7)
Colorado
- ClinRe - Thornton
Hawaii
- Pacific Vascular Institute - Kailua
Michigan
- Eastlake Cardiovascular - Roseville
New Jersey
- Englewood Hospital - Englewood
North Carolina
- Atrium Health - Charlotte
Texas
- Christus Health - Tyler
Virginia
- ClinRe - Colonial Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2027-06 |
| Phase | NA |
What the registry record for NCT05504070 still lists
NCT05504070 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, above the 109-participant average among 3 other Chronic Venous Insufficiency trials with a reported enrollment target (86% higher).
The record links to 2 conditions, with Chronic Venous Insufficiency appearing as the primary indexed condition, and to 2 interventions - of which Venclose System (digiRF generator w EVSRF catheter) is the first listed.
NCT05504070 lists 7 locations in 7 states (Colorado, Hawaii, Michigan).
Frequently Asked Questions
What is clinical trial NCT05504070 about?
NCT05504070 is a clinical study titled "Venclose digiRF System Post Market Study". A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins.
What is the current status of trial NCT05504070?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 203 participants. The study started on 2023-09-08. Estimated completion is 2027-06.
What conditions does trial NCT05504070 study?
This clinical trial studies the following conditions: Chronic Venous Insufficiency, Venous Reflux.
What interventions are being tested in trial NCT05504070?
The interventions under investigation include: Venclose System (digiRF generator w EVSRF catheter) (DEVICE), Venclose MAVEN System (digiRF generator w MAVEN catheter) (DEVICE).
Who is sponsoring clinical trial NCT05504070?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05504070 being conducted?
This trial has 7 study locations across Colorado, Hawaii, Michigan, New Jersey, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Venous Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
RECRUITING · NA
-
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)
COMPLETED · NA
-
Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI